News Digest 04.12.2023-06.12.2023
Regulators
The government approved the list of cargo for northern delivery
The government has approved a list of goods for priority deliveries to the Far North and equivalent territories. The list includes seven categories of goods: medicines, medical devices, specialized medical nutrition products, as well as fuel and energy resources, fuels and lubricants, socially important food products and essential non-food products. In total, there are about 160 items on the list, the government reported.
Regional authorities can provide businesses with budget loans for the purchase and delivery of these goods as part of the northern delivery.
Earlier in August, a law was passed creating the legal and organizational basis for northern delivery. The document comes into force on April 1, 2024. In November, the government approved a list of territories for northern delivery. The list included remote settlements in 21 regions.
A resolution was also adopted giving the Ministry of Eastern Development the authority to exercise the functions of the federal coordinator of northern deliveries. This includes monitoring, approving the route and schedule of ships within the framework of regular cabotage transportation of northern cargo between seaports, and coordinating the activities of authorities in this area.
Market news
The share of Russian medical equipment purchased by clinics exceeded 50%
The activity of domestic manufacturers of medical equipment is growing. The share of Russian products in purchases for clinics is now more than 50%. This was announced by the head of the Ministry of Health, Mikhail Murashko, at the opening of the forum “Russian Healthcare Week - 2023” and the XV All-Russian Congress of Pharmaceutical and Medical Industry Workers.
According to him, at the initial stage of the primary healthcare modernization program, the supply of domestic equipment to clinics did not exceed 20%. Murashko also called on the industry to more actively interact with chief specialists, federal institutions and regional medical organizations. This is necessary because one of the main tasks is to ensure that products meet the expectations of medical personnel, the minister explained. He added that many manufacturers have already learned to do this “very well”, with the help of experts.
The global AI market in medical imaging will grow at an average annual rate of over 33%
The global market for solutions based on artificial intelligence (AI) in the field of medical imaging will reach $14.2 billion by 2032, according to a Precedence Research forecast published by the Managed Healthcare Executive portal. North America and Europe will be the market leaders. The Asia-Pacific region can only claim third place.
Rostec is testing the first Russian complex for removing tumors with ultrasound
The Shvabe holding (part of the Rostec state corporation) is conducting clinical testing of the DIATER-M HIFU therapy complex at one of the leading Russian oncology centers. This is the first Russian solution in the field of non-invasive tumor removal using high-intensity ultrasound, according to the Rostec website.
Non-invasive tumor removal significantly reduces the rehabilitation period. This method is considered one of the safest in the world: it does not require anesthesia or the administration of strong drugs. Another advantage is the possibility of performing manipulation even if there are metal brackets, implants and metal structures in the body.
Other
A drug created by machine learning technologies has proven effective in the fight against depression.
ALTO-300, a drug for the treatment of clinical depression, developed using machine learning technologies, showed positive results in phase 2a studies. The clinical trial data was presented by Alto Neuroscience at the 62nd annual meeting of the American College of Neuropsychopharmacology, the American company said in a press release.
The study involved 239 people aged 18 to 74 who were not responding to antidepressants. In 110 of them, biomarkers of depression were determined using an electroencephalogram (EEG). The subjects continued taking antidepressants, but in combination with ALTO-300.
News
